These are top 10 stocks traded on the Robinhood UK platform in July
CHICAGO and LONDON - CME Group (market capitalization: $102.65 billion), a financial powerhouse trading near its 52-week high of $287.05, in collaboration with CF Benchmarks, has announced the upcoming launch of four new cryptocurrency reference rates and real-time indices, expanding its offerings to include Arbitrum, Ondo, NEAR, and Sui. The new benchmarks, set to roll out on June 2, 2025, aim to provide market participants with transparent and clear pricing data for these emerging digital assets. According to InvestingPro data, CME maintains strong financial health with impressive revenue growth of 11.73% over the last twelve months.
The additional reference rates will contribute to CME Group’s suite of cryptocurrency pricing benchmarks, which currently encompasses 28 digital currencies, covering over 96% of the investible cryptocurrency market capitalization. This expansion is a response to the growing need for reliable pricing data in the crypto ecosystem, as stated by Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. InvestingPro analysis reveals that CME has maintained dividend payments for 23 consecutive years, demonstrating its consistent financial stability. For detailed insights into CME’s performance metrics and future outlook, investors can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers.
CF Benchmarks CEO Sui Chung highlighted the benchmarks’ adherence to traditional financial standards of accuracy, transparency, and governance. With these new additions, institutions will be able to engage with these tokens using trusted indices, similar to those established for Bitcoin, which support regulated crypto financial products exceeding $100 billion in value.
Each reference rate will reflect the U.S. dollar price of the digital asset and will be published daily at 4 p.m. London time, while the real-time indices will be updated every second, 24/7. The Ondo and Sui reference rates will also have a daily publication at 4 p.m. New York time.
CME Group is recognized as the world’s leading derivatives marketplace, offering a wide range of products across various asset classes. The company provides a platform for trading futures, options, and over-the-counter markets, along with data analysis and risk management tools.
The announcement comes as the cryptocurrency market continues to mature, with institutions seeking more sophisticated tools to manage their exposure to digital assets. The new benchmarks from CME Group and CF Benchmarks will serve as a vital resource for investors looking to navigate the complexities of the crypto market. With 12 analysts recently revising earnings estimates upward and a consensus target price suggesting current fair valuation, CME Group continues to demonstrate strong market leadership.
The information in this article is based on a press release statement from CME Group.
In other recent news, CME Group has been the focus of several analyst updates and company announcements. Erste Group downgraded CME Group’s stock from Buy to Hold, citing an expected slowdown in turnover and net profit despite an anticipated rise in trading and hedging activities. Conversely, UBS maintained its Buy rating with a $305 price target, highlighting strong retail investor participation and the company’s robust market position. Argus Research also raised its price target to $308, reflecting optimism about growth in contract volumes amid economic and geopolitical conditions. RBC Capital Markets kept its Sector Perform rating with a $269 target, noting the company’s potential to capitalize on market volatility and international expansion.
Additionally, CME Group recently held its 2025 Annual Meeting of Shareholders, where key decisions included the election of fourteen Equity Directors and the ratification of Ernst & Young LLP as the independent public accounting firm. The shareholder meeting also addressed executive compensation, which received approval, indicating shareholder satisfaction. However, a quorum issue left certain Class B Director positions unresolved, with current directors continuing as holdovers. These developments reflect CME Group’s ongoing strategic initiatives and governance decisions, as the company navigates a dynamic financial environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.